Purchase Order 75F40124P00453
Award Date
9/18/24
Potential Completion Date
11/20/28
Potential Value
$295K
Federal Agency
Food and Drug Administration
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Laurel, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $111,255.00, was made by the Food and Drug Administration (FDA) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The award is for the provision of one (1) long-read sequencing instrument and one (1) automated library prep instrument. The contract is a firm-fixed-price purchase order with a total small business set-aside designation. It has an ultimate completion date of March 7, 2028. Oxford Nanopore Technologies Inc....
The Department of Health and Human Services Food and Drug Administration awarded a $116,289.00 firm fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, to procure a long-read DNA sequencing instrument and associated automated library preparation instrument. The contract has no set-aside designation. The requirement was originally solicited through a competitive process, with Oxford Nanopore securing the award on September 16, 2021. Oxford...
This is a firm fixed price contract awarded by the Department of Health and Human Services Food and Drug Administration to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for the lease of a sensitive long fragment DNA sequencing device. The contract has a potential value of $88,755.00 and a completion date of September 29, 2027. There is no set-aside designation for this award. The original solicitation was a combined synopsis/solicitation posted on May...
This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, provides a software license and device warranty for two GridION instruments to support the Food and Drug Administration's (FDA) next-generation sequencing efforts. The $25,000.00 firm-fixed-price purchase order has a period of performance through September 27, 2025. Oxford Nanopore Technologies is a provider of innovative nanopore-based sequencing platforms, which have been...
This federal contract award is for the purchase of specific supplies and reagents for an Oxford Nanopore GridION instrument, awarded to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract, valued at $29,162.00, is a firm fixed-price purchase order placed by the Food and Drug Administration (FDA), a civilian government agency. The award is not associated with a set-aside program and has an ultimate completion date of March 29, 2024. Oxford Nanopore...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for a service contract to provide Oxford Nanopore GridION instruments. The contract has a total ceiling value of $50,000.00 and a completion date of February 5, 2023. The contract is not associated with any set-aside designation. Oxford Nanopore Technologies Inc. is a provider of next-generation genomic...
This is a $125,000.00 firm fixed price purchase order awarded by the Food and Drug Administration (FDA) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for a service agreement to provide Oxford Nanopore's GridION instruments located at the FDA's Center for Food Safety and Applied Nutrition, Office of Regulatory Science. This award is not set aside for any small business program. Oxford Nanopore has secured numerous federal contracts to...
Oxford Nanopore Technologies Inc. was awarded a $25,000 firm fixed price purchase order by the Department of Health and Human Services Food and Drug Administration to deliver GridION software licenses. The solicitation sought GridION software or equal, including device warranty. As a foreign owned for-profit organization, Oxford Nanopore Technologies Inc. develops nanopore sequencing systems and supplies consumables to support genomic research. They have provided equipment, reagents, kits and...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $225,000.00 firm fixed-price purchase order contract to Oxford Nanopore Technologies Inc., a division of Oxford Nanopore Technologies PLC, for a PromethION 24 compact benchtop sequencing system. This system is designed to run and analyze up to 24 PromethION Flow Cells, delivering yields of up to 4,800 Gigabases. The contract has a one-year base period with three one-year option years. This award was...
Oxford Nanopore Technologies Inc. was awarded a $100,060 firm fixed-price purchase order by the U.S. Department of Health and Human Services Food and Drug Administration (FDA) for a total small business set-aside requirement of two portable long-read whole genome sequencers to support the FDA's epidemiologic investigations and surveillance for foodborne pathogens like Escherichia coli and Clostridium botulinum. The sequencers and associated consumables, support, and installation services are...